Skip to content
Find an ETF
← All ETFs

Available in 10 markets

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

Xtrackers · IE000KD0BZ68

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is an exchange-traded fund (ETF) from Xtrackers, traded under the ticker XGES (ISIN IE000KD0BZ68). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. At its core it is a focused, thematic fund: it concentrates on the health care part of the market,…

· Tracks the MSCI ACWI IMI Genomic Innovation Select Screened 100 Index index ?
Equity ?Accumulating ?Physical ?Ireland ?
Mid-range feeReinvests dividendsOwns the shares directlyGlobalConcentrated in a few names
Fund size (AUM) ?
€0
Risk level (SRI) ?
6 / 7 · High
1-year return ?
+30.1%
Price Return · to 2026-11-04
Yearly fee (TER) ?
0.30%
All-in cost ≈ 0.30%

About this fund

What you own

The MSCI ACWI IMI Genomic Innovation Select Screened 100 Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 117 companies across Global in a single purchase.

Dividends

The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.

Read more

Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.

How it works

The fund actually buys every share in the index it tracks (full replication).

Read more

Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.

Cost

0.30%Yearly fee (TER)
0.30%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Index tracked ?
MSCI ACWI IMI Genomic Innovation Select Screened 100 Index
Replication ?
Physical
Full — buys every share
Regulation ?
UCITS
Yes
Launched
2022
4-year track record

Performance

95.698.4101104107202620262026

Growth of $100 invested — both lines start at $100.

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C Average MSCI ACWI IMI Genomic Innovation Select Screened 100 Index ETF (funds we track) ?

Compared with the average fund tracking the same index — our own data, not the licensed index itself.

YTD+29.2%
1 year+30.1%
3 years+16.0%

Return, year by year

-7.9
-1.4
+11.2
'23'24'25
1 of 3 up yearsBest: 2025 +11.2%Worst: 2023 -7.9%Calendar-year total returns, in USD

How bumpy has it been?

21.3%
Volatility (1y) ?
How much the price swings year to year — lower is calmer.
-30.0%
Worst drop (3y) ?
The biggest fall from a peak over the last three years.
0.45
Return for the risk (3y) ?
Reward earned per unit of bumpiness.

The bigger picture

+1.9%
Since inception
Total growth since launch — about +0.4% a year.
+73.9%
Best 12 months
The strongest one-year stretch on record.
-27.9%
Worst 12 months
The weakest one-year stretch on record.
-42.9%
Worst fall on record ?
It clawed back in about 7 months.

What's inside

By sector ?

Health Care96.0%
Cash/Other4.0%
Financials0.0%

The 10 biggest holdings make up 48.6% of the fund — the rest is spread across roughly 106 more companies.

Top 10 holdings

#CompanyWeight
1MODERNA6.2%
2ILLUMINA INC6.1%
3NATERA5.6%
4AGILENT TECHNOLOGIES INC5.0%
5DANAHER4.9%
6LONZA GROUP AG4.6%
7ROCHE PS PAR AG4.4%
8VERTEX PHARMACEUTICALS4.2%
9GSK AMERICAN DEPOSITORY SHARES REP4.2%
10GUARDANT HEALTH3.6%

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
LSEXGESUSD★ Primary
CHF listings
SIXXGENCHF
EUR listings
Borsa ItalianaXGENEUR
FrankfurtXGENEUR
USD listings
E1XGENEURUSD
E1XGENGBPUSD
E1XGENUSDUSD
E1XGENCHFUSD
EPXGENCHFUSD
EPXGENEURUSD
ERXGENMUSD
ERXGENPLNUSD
ERXGENUSDUSD
ERXGENLUSDUSD
ERXGENGBPUSD
ERXGENMUSDUSD
ERXGENUSD
ERXGENCHFUSD
ERXGENDUSD
ERXGENDUSDUSD
EUXGENUSDUSD
EUXGENGBPUSD
EUXGENEURUSD
EUXGENCHFUSD
EZXGENCHFUSD
EZXGENEURUSD
GDXGENUSD
GHXGENUSD
GMXGENUSD
GSXGENUSD
GTXGENUSD
GZXGENUSD
LAXGENUSD
LSEXGENUSD
LUXGENUSD
MFXGENNUSD
MMXGENNUSD
MUXGENNUSD
QTXGENUSD
SEXGENUSD
THXGENUSD
X1XGENUSDUSD
X1XGENGBPUSD
X1XGENEURUSD
X1XGENCHFUSD
X2XGENCHFUSD
X2XGENEURUSD
X2XGENGBPUSD
X2XGENUSDUSD
X9XGENEURUSD
XAXGENCHFUSD
XAXGENEURUSD
XAXGENGBPUSD
XAXGENUSDUSD
XEXGENUSDUSD
XEXGENGBPUSD
XEXGENEURUSD
XEXGENCHFUSD
XFXGENCHFUSD
XFXGENEURUSD
XFXGENGBPUSD
XFXGENUSDUSD
XGXGENUSDUSD
XGXGENGBPUSD
XGXGENEURUSD
XGXGENCHFUSD
XHXGENCHFUSD
XHXGENEURUSD
XHXGENGBPUSD
XHXGENUSDUSD
XJXGENUSDUSD
XJXGENGBPUSD
XJXGENEURUSD
XJXGENCHFUSD
XLXGENCHFUSD
XLXGENEURUSD
XLXGENGBPUSD
XLXGENUSDUSD
XOXGENUSDUSD
XOXGENGBPUSD
XOXGENEURUSD
XOXGENCHFUSD
XQXGENUSDUSD
XQXGENGBPUSD
XQXGENEURUSD
XQXGENCHFUSD
XSXGENCHFUSD
XSXGENEURUSD
XSXGENGBPUSD
XSXGENUSDUSD
XTXGENCHFUSD
XUXGENUSDUSD
XUXGENGBPUSD
XUXGENEURUSD
XUXGENCHFUSD
XVXGENCHFUSD
XVXGENEURUSD
XVXGENGBPUSD
XVXGENUSDUSD
XWXGENUSDUSD
XWXGENGBPUSD
XWXGENEURUSD
XWXGENCHFUSD
XXXGENCHFUSD
XXXGENEURUSD
XXXGENGBPUSD
XXXGENUSDUSD
XYXGENUSDUSD
XYXGENGBPUSD
XYXGENEURUSD
XYXGENCHFUSD
XZXGENCHFUSD
XZXGENEURUSD
XZXGENGBPUSD
XZXGENUSDUSD
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

Full holdings

As of 2026-11-04 · the fund's own published holdings.

#CompanyWeight
1MODERNA6.2%
2ILLUMINA INC6.1%
3NATERA5.6%
4AGILENT TECHNOLOGIES INC5.0%
5DANAHER4.9%
6LONZA GROUP AG4.6%
7ROCHE PS PAR AG4.4%
8VERTEX PHARMACEUTICALS4.2%
9GSK AMERICAN DEPOSITORY SHARES REP4.2%
10GUARDANT HEALTH3.6%
11ARGENX SE ADR3.2%
12WUXI BIOLOGICS CAYMAN3.1%
13REVVITY2.8%
14MEDPACE HOLDINGS2.7%
15INSMED2.7%
16SANDOZ GROUP AG2.0%
17QIAGEN1.9%
18INNOVENT BIOLOGICS1.7%
19BEONE MEDICINES AG1.7%
20QUEST DIAGNOSTICS INC1.7%
21BIO TECHNE1.6%
22TWIST BIOSCIENCE1.5%
23EXELIXIS INC1.3%
24MADRIGAL PHARMACEUTICALS1.2%
25KRYSTAL BIOTECH1.2%
26TEMPUS AI CLASS A1.1%
27ROIVANT SCIENCES LTD1.1%
2810X GENOMICS CLASS A1.1%
29BRIDGEBIO PHARMA0.9%
30GENSCRIPT BIOTECH -1K CORP0.8%
31ARROWHEAD PHARMACEUTICALS0.8%
32CRISPR THERAPEUTICS AG0.8%
33BRUKER0.7%
34BIOMARIN PHARMACEUTICAL0.7%
35VERACYTE0.7%
36COGENT BIOSCIENCES0.6%
37CYTOKINETICS0.5%
38VAXCYTE0.5%
39JIANGSU HENGRUI MEDICINE LTD A0.5%
40ORUKA THERAPEUTICS0.5%
41PRAXIS PRECISION MEDICINES0.4%
42BEAM THERAPEUTICS0.4%
43KINIKSA PHARMACEUTICALS INTERNATIO0.3%
44TANGO THERAPEUTICS0.3%
45IDEAYA BIOSCIENCES0.3%
46VIKING THERAPEUTICS0.3%
47BIO RAD LABORATORIES CLASS A0.3%
48GRIFOLS CLASS A0.3%
49INTELLIA THERAPEUTICS0.3%
50RELAY THERAPEUTICS0.3%
51ADAPTIVE BIOTECHNOLOGIES0.3%
52LEGEND BIOTECH ADR REP0.2%
53BIOARCTIC CLASS B0.2%
54NEWAMSTERDAM PHARMA0.2%
55OXFORD NANOPORE TECHNOLOGIES PLC0.2%
56SAREPTA THERAPEUTICS0.2%
57MBX BIOSCIENCES0.2%
58HINGE HEALTH CLASS A0.2%
59SHENZHEN MINDRAY BIO-MEDICAL ELECT0.2%
60AMYLYX PHARMACEUTICALS0.2%
61DYNE THERAPEUTICS0.2%
62DIANTHUS THERAPEUTICS0.2%
63MESOBLAST ADR REPRESENTING0.2%
64ROCHE HOLDING AG0.2%
65ENLIVEN THERAPEUTICS0.2%
66VIRIDIAN THERAPEUTICS ORS0.2%
67KYOWA KIRIN LTD0.2%
68SCHOLAR ROCK HOLDING0.2%
69ARCUS BIOSCIENCES0.2%
70FORTREA HOLDINGS INC0.2%
71NURIX THERAPEUTICS0.1%
72IMMUNOVANT0.1%
73CELLDEX THERAPEUTICS0.1%
74VERICEL0.1%
75INHIBRX BIOSCIENCES INC0.1%
76DIASORIN0.1%
77CORVEL0.1%
78TREVI THERAPEUTICS0.1%
79PALVELLA THERAPEUTICS INC0.1%
80RECURSION PHARMACEUTICALS CLASS A0.1%
81ACADIA PHARMACEUTICALS0.1%
82TAYSHA GENE THERAPIES0.1%
83BIOHAVEN0.1%
84NEKTAR THERAPEUTICS0.1%
85ULTRAGENYX PHARMACEUTICAL0.1%
86UNIQURE0.1%
88CELCUITY0.1%
89DISC MEDICINE0.1%
90PHARMARON BEIJING LTD A0.1%
91OLIX PHARMACEUTICALS INC0.1%
92PHARMA MAR SA0.1%
93SYNDAX PHARMACEUTICALS0.1%
94CARSGEN THERAPEUTICS LTD0.1%
95TYRA BIOSCIENCES0.1%
96STOKE THERAPEUTICS0.1%
97HONG KONG DOLLAR0.1%
98ALUMIS0.0%
99SHENZHEN NEW INDUSTRIES BIOMEDICAL0.0%
100US DOLLAR0.0%
101CAPRICOR THERAPEUTICS0.0%
102HANGZHOU TIGERMED CONSULTING LTD A0.0%
103SOUTH KOREAN WON0.0%
104YUAN RENMINBI0.0%
105EURO CURRENCY0.0%
106SWISS FRANC0.0%
107SWEDISH KRONA0.0%
108POUND STERLING0.0%
109JAPANESE YEN0.0%
110NEW TAIWAN DOLLAR0.0%
111AUSTRALIAN DOLLAR0.0%
112CANADIAN DOLLAR0.0%
113DANISH KRONE0.0%
114-0.0%
115CONTRA MIRATI THERAPEU0.0%
116CONTRA CHINOOK THERAPE0.0%
117CONTRA ARCELLX INC0.0%

⭳ Download full holdings (CSV)

How it ranks vs peers

🪙 Cheaper than 5% of similar ETFs💰 All-in cost cheaper than 23%📈 Higher 1-yr return than 95%📈 Higher 3-yr return than 13%📊 Behind its category by 581.9% (1-yr) (category average +612.0%)📊 Behind its category by 2.3% (3-yr) (category average +18.3%)

Versus the Equity (stocks) · Global · GBP ETFs we track.

Advanced risk

0.80
Sortino (3y) ?
0.53
Calmar (3y) ?
13.1%
Downside deviation ?
42%
Up months (hit rate) ?
$34.63
52-week high ?
$23.27
52-week low ?

Concentration depth

~31 ?
Effective number of holdings

Roughly 117 companies are held, but the largest names carry most of the weight — so it behaves like ~31 equal-sized positions.

Tilt vs a world tracker

Health Care+96.0
Cash/Other-74.2
Cash/Other-70.2
United States+52.1
Technology-16.3
Switzerland+11.0

Percentage points over / under a broad world-equity tracker (not a licensed benchmark).

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 Global stocks
Compare side by side
6 similar funds
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1CXtrackersYou're viewingiShares Core MSCI World UCITS ETFiSharesBroader matchiShares Core MSCI World UCITS ETFiSharesBroader matchiShares Core MSCI World UCITS ETFiSharesBroader matchiShares Core MSCI World UCITS ETFiSharesBroader matchState Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader matchiShares MSCI ACWI UCITS ETFiSharesBroader match
Why it's similarThis is the fund on this page.
StocksPhysical
Tracks a different index in the same category.
StocksPhysical
Tracks a different index in the same category.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
StocksAccumulatingPhysicalCheaper fee
Tracks a different index in the same category.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
StocksPhysicalCheaper fee
Tracks a different index in the same category.
Index trackedMSCI ACWI IMI Genomic Innovation Select Screened 100 IndexMSCI WorldMSCI WorldMSCI WorldMSCI WorldS&P Developed Ex-U.S. BMI IndexMSCI ACWI
Yearly fee (TER)0.30%0.30%0.30%0.20%0.20%0.03%0.20%
All-in cost0.30%0.30%0.00%0.20%0.20%0.00%0.20%
Fund size€0€172.9B€146.5B€130.6B€127.6B€36.9B€31.5B
DomicileIrelandIrelandIrelandIrelandIrelandUnited StatesIreland
ReplicationPhysical (full)Physical (full)Physical (full)Physical (full)Physical (full)Physical (full)Physical (full)
3-yr return p.a.+16.0%+16.8%+17.8%+23.5%+18.3%+15.8%
5-yr return p.a.+9.7%+9.3%+11.3%+5.0%
# holdings1171,3561,3561,3561,3562,4661,738

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-11-04 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.